India’s Regulatory Headwinds, Drug Quality Issues Take Center Stage At BioAsia 2014
This article was originally published in PharmAsia News
Executive Summary
BioAsia 2014 in India’s southern city of Hyderabad, brought out the contradictions inherent in the country’s drug industry, which has evolved from being a new player on the international stage a decade ago. But scrutiny over regulatory compliance and intellectual property issues often dwarf progress made.